Tango Therapeutics (TNGX) Q2 2025 Earnings

12MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.37
-0.32
-0.28
-0.24

Details

Expected EPS
-0.350143
Actual EPS
-0.36
Surprise EPS
-0.01
Surprise Percent
+2.82%

Description

Tango Therapeutics (TNGX) has reported earnings of -0.36 per share for Q2 2025.

0 Comments

Share your thoughts